METASTATIC SARCOMATOID RENAL CELL CARCINOMA
Clinical trials for METASTATIC SARCOMATOID RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SARCOMATOID RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SARCOMATOID RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: METASTATIC SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Gut bacteria joins fight against advanced kidney cancer
Disease control Recruiting nowThis early-stage study is testing whether adding a specific gut bacteria supplement, called EXL01, makes standard immunotherapy drugs (nivolumab and ipilimumab) safer and more effective for people with advanced kidney cancer that has spread. The goal is to see if changing the gut…
Matched conditions: METASTATIC SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Gut health boost joins fight against advanced kidney cancer
Disease control Recruiting nowThis study is testing whether adding a gel made from inulin, a common dietary fiber, makes standard immunotherapy drugs more effective for people with advanced kidney cancer. Researchers think improving gut bacteria health might help the immune system fight cancer better. The tri…
Matched conditions: METASTATIC SARCOMATOID RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Feb 25, 2026 15:08 UTC